Abstract: An assistance apparatus for issuing a handling recommendation to an operator who is undertaking an operative intervention on an object includes an object identification unit for identification of the object. The assistance apparatus includes an operator identification unit for identification of the operator, a first memory unit for storage of the characteristic object data describing the identified object, and a second memory unit for storage of the characteristic operator data describing the identified operator. The assistance apparatus includes a specification unit for specifying the intervention to be undertaken on the object, a preparation unit that is in communication with the specification unit and is configured to procure and to store intervention-related operation data.

Abstract: A system for automatic categorization and assessment of billing narratives has a semantic engine that classifies billing entries with descriptions expressed in natural language into standardized categories of activity and task objective. The classification is by machine learning methods via training data that is maintained, updated and extended as needed. A rules engine applies rules to the categorized invoice data to analyze the data, report violations to a user/consumer of billed services and to perform related calculations.

Abstract: The present invention relates to in vitro methods for production of liver organoids.

Abstract: A system for automatic categorization and assessment of billing narratives has a semantic engine that classifies billing entries with descriptions expressed in natural language into standardized categories of activity and task objective. The classification is by machine learning methods via training data that is maintained, updated and extended as needed. A rules engine applies rules to the categorized invoice data to analyze the data, report violations to a user/consumer of billed services and to perform related calculations.

Abstract: A system for automatic categorization and assessment of billing narratives has a semantic engine that classifies billing entries with descriptions expressed in natural language into standardized categories of activity and task objective. The classification is by machine learning methods via training data that is maintained, updated and extended as needed. A rules engine applies rules to the categorized invoice data to analyze the data, report violations to a user/consumer of billed services and to perform related calculations.

Abstract: Systems and methods of monitoring medication compliance are provided. A first node receives from a second node a picture of a pill bottle label and a picture of the number of pills in the pill bottle. The information on the label is predicted from the picture of the pill bottle. The medication and number of pills is predicted from the picture of the number of pills. Information associated with compliance to the dosage regimen of the medication is determined based on the predicted number of pills and the dosage regimen. The second node sends to the first node an indication of the information associated with the medication compliance.

Abstract: A system for automatic categorization and assessment of billing narratives has a semantic engine that classifies billing entries with descriptions expressed in natural language into standardized categories of activity and task objective. The classification is by machine learning methods via training data that is maintained, updated and extended as needed. A rules engine applies rules to the categorized invoice data to analyze the data, report violations to a user/consumer of billed services and to perform related calculations.

Abstract: Disclosed are CRTH2 inhibitors represented by Structural Formula (I): The values for the variables of Structural Formula (I) are provided herein.

Abstract: A method for the enabling or blocking of an operating mode in a medical diagnostic device enables the operating mode of the diagnostic device only after successful verification of the consumable material required for the operational mode. The consumable material is identified by a machine-readable identification tag, which is read off by a reading device.

Abstract: A system and method of providing after sales support for medical systems is described. During the economic lifetime of a medical system, new or modified software modules may become available as a result of advances in medical knowledge or the technology of the medical system. Such updates or improvements may be provided to customers with suitable existing medical systems by making such modules available for licensing on a pay-per-use or a paid-up license basis. Information regarding the after sales support is maintained on a data base by the manufacturer and provided to customers over a wide-area network. The information may be customized on the basis of the existing configuration of the customer medical system to indicate the additional modules that are available.

Abstract: A device and a method are disclosed for access to at least one information item, which relates to at least one medicament, by a user, in particular in a hospital. At least one mobile electronic appliance is provided for carrying by the user. The appliance includes a reading device which is designed for reading an electronically legible identification which identifies the medicament. The mobile appliance includes a data link to at least one appliance-internal and/or -external memory device in which the information relating to the medicament is stored in such a manner that it is made available to the user via the mobile appliance as a function of the reading of the electronically legible identification of the medicament.

Abstract: Disclosed herein are compounds represented by Structural Formula (I): (I), wherein the variables are defined herein. Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.

Abstract: Disclosed are CRTH2 inhibitors represented by Structural Formula (I): The values for the variables of Structural Formula (I) are provided herein.

Abstract: Disclosed herein are compounds represented by Structural Formula (I): (I), wherein the variables are defined herein. Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.

Abstract: Disclosed herein are compounds represented by Structural Formula (I) and (I-A): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.

Abstract: A method for the enabling or blocking of an operating mode in a medical diagnostic device enables the operating mode of the diagnostic device only after successful verification of the consumable material required for the operational mode. The consumable material is identified by a machine-readable identification tag, which is read off by a reading device.

Abstract: Disclosed herein are compounds represented by Structural Formula (I): 1